HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian D Green Selected Research

gastric inhibitory polypeptide receptor

6/2007Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob mice.
2/2007Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) mice.
7/2006Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).
9/2005A novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetes.
8/2005Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brian D Green Research Topics

Disease

24Type 2 Diabetes Mellitus (MODY)
12/2019 - 12/2003
13Obesity
04/2022 - 08/2005
13Body Weight (Weight, Body)
01/2018 - 09/2004
13Insulin Resistance
08/2010 - 09/2004
10Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2014
4Hypertrophy
04/2022 - 08/2005
4Dementia (Dementias)
01/2021 - 01/2014
3Myocardial Infarction
04/2016 - 08/2009
3Inflammation (Inflammations)
01/2016 - 02/2015
3Heart Failure
01/2016 - 08/2009
2Delirium
01/2021 - 12/2019
2Cognitive Dysfunction
12/2019 - 01/2015
2Infarction (Infarctions)
04/2016 - 01/2016
2Cardiovascular Diseases (Cardiovascular Disease)
04/2016 - 02/2015
2Fibrosis (Cirrhosis)
01/2016 - 03/2015
2Glucose Intolerance
12/2015 - 02/2006
2Weight Gain
08/2010 - 12/2006
1Fatty Liver
04/2022
1Hepatocellular Carcinoma (Hepatoma)
04/2022
1Bacterial Infections (Bacterial Infection)
01/2022
1COVID-19
01/2021
1Emergence Delirium
12/2019
1Colorectal Neoplasms (Colorectal Cancer)
11/2019
1Cardiomegaly (Heart Hypertrophy)
04/2016
1Huntington Disease (Huntington's Disease)
01/2016
1Reperfusion Injury
01/2016
1Hypertension (High Blood Pressure)
02/2015
1Hypoglycemia (Reactive Hypoglycemia)
08/2010
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
08/2009
1Neoplasms (Cancer)
05/2008
1Rheumatoid Arthritis
05/2008
1Liver Diseases (Liver Disease)
05/2008
1Osteoporosis
05/2008
1Feeding and Eating Disorders (Eating Disorder)
05/2008
1Crohn Disease (Crohn's Disease)
05/2008
1Multiple Sclerosis
05/2008

Drug/Important Bio-Agent (IBA)

15Glucose (Dextrose)FDA LinkGeneric
02/2015 - 08/2005
14Insulin (Novolin)FDA Link
01/2018 - 08/2005
12Glucagon-Like Peptide 1 (GLP 1)IBA
04/2016 - 01/2004
7Peptides (Polypeptides)IBA
01/2018 - 09/2005
6Hormones (Hormone)IBA
03/2015 - 12/2003
5IncretinsIBA
02/2015 - 12/2003
5gastric inhibitory polypeptide receptorIBA
06/2007 - 08/2005
4EnzymesIBA
01/2019 - 12/2006
4GhrelinIBA
01/2018 - 09/2010
4Pro(3)- glucose-dependent insulinotropic polypeptideIBA
02/2007 - 09/2004
3PolyaminesIBA
01/2021 - 01/2015
3Fatty Acids (Saturated Fatty Acids)IBA
10/2018 - 09/2005
3Glucagon (Glukagon)FDA Link
04/2016 - 12/2003
3Exenatide (Byetta)FDA Link
01/2016 - 02/2010
3Hypoglycemic Agents (Hypoglycemics)IBA
08/2010 - 01/2004
3Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
05/2008 - 10/2006
3Dipeptidyl-Peptidase IV InhibitorsIBA
07/2007 - 09/2006
2Biomarkers (Surrogate Marker)IBA
12/2019 - 01/2016
2Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
09/2006 - 09/2005
1PhytochemicalsIBA
04/2022
1Prostaglandins GIBA
04/2022
1Anti-Infective Agents (Microbicides)IBA
01/2022
1Polysaccharides (Glycans)IBA
01/2022
1Glycerol (Glycerine)FDA LinkGeneric
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Amino AcidsFDA Link
01/2021
1SphingolipidsIBA
01/2021
1Monoamine Oxidase (MAO)IBA
01/2021
1LipidsIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Glutamine (L-Glutamine)FDA Link
12/2019
1Persistent Organic PollutantsIBA
12/2019
1PutrescineIBA
12/2019
1SpermidineIBA
12/2019
1NitritesIBA
11/2019
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2019
1Biological ProductsIBA
01/2018
1AcidsIBA
01/2018
1Bile Acids and Salts (Bile Acids)IBA
06/2017
1Alanine (L-Alanine)FDA Link
11/2016
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
04/2016
1SecretagoguesIBA
04/2016
1CytokinesIBA
01/2016
1Whey ProteinsIBA
12/2015
1Arginine (L-Arginine)FDA Link
01/2015
1Adenosine Triphosphatases (ATPase)IBA
01/2015
1IonsIBA
01/2015
1alpha-Glucosidases (Acid Maltase)IBA
10/2014
1ZincIBA
01/2014
1CopperIBA
01/2014
1IronIBA
01/2014
1Peptide Hormones (Polypeptide Hormones)IBA
12/2012
1Sitagliptin Phosphate (Januvia)FDA Link
08/2010
1TabletsIBA
08/2010
1Pioglitazone (Actos)FDA Link
08/2010
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
02/2010
1Nateglinide (Starlix)FDA LinkGeneric
12/2009
1dipeptidaseIBA
05/2008
1Hyp(3)- glucose-dependent insulinotropic polypeptideIBA
06/2007
1Hyp(3)-palmitoylLys(16)- glucose-dependent insulinotropic polypeptideIBA
06/2007

Therapy/Procedure

11Therapeutics
01/2018 - 01/2004
3Injections
06/2007 - 09/2005
1Knee Replacement Arthroplasty (Total Knee Replacement)
12/2019
1Arthroplasty
12/2019